Hims & Hers Health has stopped offering a weight-loss pill after facing threats of legal action, marking a significant retreat in the telehealth company's aggressive push into the booming GLP-1 weight-loss market dominated by pharmaceutical giants Novo Nordisk and Eli Lilly.